Animal Antibiotics and Antimicrobials Market Research Report - Global Forecast till 2027

Animal Antibiotics and Antimicrobials Market Research Report Information by Delivery Type (Injections, Oral powder, Oral solutions, Premixes, Others), Product Type (Aminocoumarins, Aminoglycosides, Bicyclomycin, etc) and Region - Forecast To 2027.

ID: MRFR/Pharma/5217-HCR | February 2021 | Region: Global | 100 pages

Animal Antibiotics and Antimicrobials Market Snapshot


In the Healthcare industry, medicines and antibiotics have always been used to cure bacterial infection. Such medicines are made not just from plant extracts but also from animal extracts. Currently, the animal antibiotics and antimicrobials market is expected to grow between the forecast period between 2017 and 2023 with the 4.50% CAGR (Compound Annual Growth Rate). In terms of cash, the market that is worth US $ 3.9 bn in 2017 is expected to be worth US $ 5.2 bn in 2023.


Companies Covered


Bayer Animal Health, Bioniche Animal Health, Ceva Sante Animale S.A., Elanco Animal Health, Fort Dodge Animal Health, Merck Animal Health, Merial, Novartis Animal Health, Phibro Animal Health Corp., Virbac Animal Health, and Zoetis.

Market Segmentation


The animal antibiotics and antimicrobials market has been segmented on the basis of delivery type, end user type, product type, and region. Based on delivery type, this market has been segmented into injections, oral powder, oral solutions, premixes, and others. Regarding the end user types, the market segmentation covers companion animals and food producing animals. Segmentation based on product type segments the market into aminocoumarins, aminoglycosides, bicyclomycin, cephalosporins, fluoroquinolones, fusidic acid, macrolides, penicillin, phenicols, sulfonamides, and tetracyclines.


Segmental Analysis:


For the scope of research, MRFR’s report offers a comprehensive segmental analysis of the animal antibiotics and antimicrobials market.


Animal Antibiotics and Antimicrobials Market By Delivery Type



  • Injections

  • Oral powder

  • Oral solutions

  • Premixes

  • Others


Animal Antibiotics and Antimicrobials Market By End User Type



  • Companion animals

  • Food producing animals


Animal Antibiotics and Antimicrobials Market By Product Type



  • Aminocoumarins

  • Aminoglycosides

  • Bicyclomycin

  • Cephalosporins

  • Fluoroquinolones

  • Fusidic acid

  • Macrolides

  • Penicillin

  • Phenicols

  • Sulfonamides

  • Tetracyclines


Report Overview:


This MRFR report presents an nonpartisan analysis of key market trends in the Animal Antibiotics and Antimicrobials Market. It includes a detailed discourse on current market status, growth opportunities, historical trends, segmental revenue, and challenges backed by fact-based feedbacks. The report segments the animal antibiotics and antimicrobials market on the basis of delivery type, end user type, product type, and region. The delivery types covered in this report are injections, oral powder, oral solutions, premixes, and others. The end user types mentioned in this report are companion animals and food producing animals. The product types discussed in this report are aminocoumarins, aminoglycosides, bicyclomycin, cephalosporins, fluoroquinolones, fusidic acid, macrolides, penicillin, phenicols, sulfonamides, and tetracyclines. All market segments and sub-segments have been profiled under regions such as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA) with respective country-level analysis.


Report Coverage:


The report on animal antibiotics and antimicrobials market covers competitive landscape, current market dynamics, country-level break down for each market segment, historical market trends, key players' market share analysis, market valuation based on segmental as well as regional analysis, and supply chain analysis.


Animal Antibiotics and Antimicrobials Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • Latin America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa



Research Methodology:


Market Research Future (MRFR) endeavors to display errorless interpretation of market size and value via vital statistical The market size and sub-market prospects validated from the conclusions drawn via top-down and bottom-up perspectives. All variables that have the potential to impact market growth are weighed through scientific methods. Market insights regarding constraints, probabilities, contingencies, and trends are found after reviewing all the applicable elements assiduously. Primary research methods gather information via interviews with key decision makers of market-leading companies. The secondary research methods offer a detailed analysis of all applicable information via reference to researches available in the public domain. Credible sources such as annual reports, SEC filings, and white papers are used for fusion of unique intelligent inputs.



Report Scope:
Report Attribute/Metric Details
  Market Size   2017: USD 3.9 Billion
  CAGR   4.50% (2018 - 2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Delivery Type, Product Type, Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer Animal Health, Bioniche Animal Health, Ceva Sante Animale S.A., Elanco Animal Health, Fort Dodge Animal Health, Merck Animal Health, Merial, Novartis Animal Health, Phibro Animal Health Corp., Virbac Animal Health, and Zoetis.
  Key Market Opportunities   Increasing research & development investments by major industry players
  Key Market Drivers

  • Growing demand for animal derived food products
  • Increasing animal health expenditure


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The animal antibiotics and antimicrobials market are projected to grow at a 4.50% CAGR between 2020-2027.

    The animal antibiotics and antimicrobials market are predicted to touch USD 5.2 billion by 2023.

    North America is projected to command the largest share in the animal antibiotics and antimicrobials market.

    Growing demand for animal derived food products and increasing animal health expenditure are boosting market growth.

    Growing resistance to antibiotics may limit market growth.